John Osborn Showart

Episode 126: December 01, 2019

Americans like their prescription drugs. According to WebMD, the number of prescriptions filled for Americans rose 85% between 1997 and 2016. That’s four times the population growth during that same period. While many Americans count on their prescription drugs, many also have an unfavorable opinion of the pharmaceutical industry. John Osborn is a senior advisor with the Washington office of the international law firm Hogan Lovells. He spent over 20 years with leading life sciences and healthcare companies. Osborn recently visited William & Mary as a guest of the Schroeder Center for Health Policy. He spoke with students about the pharmaceutical industry, drug pricing, and health policy issues. Afterwards, he spoke with us.

Podcast (audio)

Podcast (platforms)

iTunes | Stitcher | SoundCloud | TuneIn

  • What is the prevailing public opinion of the pharmaceutical industry
  • Why is there a largely unfavorable opinion on pharmaceutical companies
  • Is there a drug pricing problem in the United States
  • What are the microeconomic vs macroeconomic differences of drug pricing
  • Is it harder to find investors in the pharmaceutical arena compared to other businesses
  • What is the failure rate of start-up drug companies
  • Is there a generic drug for every brand-name drug
  • What are lawmakers doing to address prescription drug pricing
  • What are drug manufacturers doing to combat high drug prices
More Podcast Episodes